State health officials issue technical bulletin with details The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the Novavax COVID-19 Vaccine, Adjuvanted in individuals 18 years of age and older for the prevention of COVID-19. By authorizing an additional COVID-19 vaccine, adults in the United States who have not yet received a COVID-19 vaccine now have more available options. This vaccine contains the SARS-CoV-2 spike protein and Matrix-M adjuvant. Adjuvants are ingredients used in some vaccines that help to create a stronger immune response for the vaccinated individual.
The Nevada Department of Health and Human Services has issued a technical bulletin that summarizes the recent Novavax COVID-19 Vaccine, Adjuvanted eligibility recommended for individuals ages 18 years of age and older. At this time, Novavax is not authorized to be used as a booster dose and individuals receiving a Novavax primary series are not eligible for a booster dose of any COVID-19 vaccines. Click here to access the Technical Bulletins web page and look for the most recent bulletin, “Novavax COVID-19 Vaccine, Adjuvanted Authorized for Emergency Use Authorization.”
0 Comments
Leave a Reply. |
AuthorThe Bureau of Health Care Quality and Compliance (HCQC) licenses medical and other health facilities, child care facilities and personnel, and medical laboratories and personnel in Nevada. HCQC also conducts compliance surveys and takes complaints. Archives
October 2023
Categories
All
|